RESIST-TB webinar: PHOENIx trial

RESIST-TB will host a webinar, Protecting MDR-TB and XDR-TB Affected Households: The PHOENIx MDR-TB Trial on Thursday, January 19th from 08:30 to 09:30 EST (13:30-14:30 CET, 14:30-15:30 SAST).

Read More →

Multidrug-resistant TB prevention trials to begin

Three recent clinical trials – VQUIN, TB-CHAMP, and PHOENIx – are focusing on preventing MDR-TB among household contacts of MDR-TB patients. Two trials, VQUIN and TB-CHAMP, are studying the efficacy of levofloxacin compared to placebo treatment among household contacts. The VQUIN trial enrolled its first subject on March 14, 2016, while the TB-CHAMP trial is set to begin enrollment in Q4 of 2016. The PHOENix trial is focused on testing the efficacy of delamanid versus isoniazid treatment, and is the least far along. PHOENIx has completed a successful pilot trial and hopes to begin enrollment sometime in 2017.

Read More →

Webinar: Identification of patients who could benefit from bedaquiline or delamanid

The webinar will be held Wednesday, March 16, 2016 at 09:00 EST (14:00 CET)
Presenter: Dr. Maryline Bonnet, Epicentre

Read More →

International consensus statement on molecular diagnosis of tuberculosis drug-resistance released

Multidrug-resistant (MDR) and extensively drug-resistant tuberculosis (XDR-TB) are challenging tuberculosis control globally. Early identification of patients with MDR-TB and XDR-TB and the complex pattern of Mycobacterium tuberculosis drug resistance are key to providing each individual patient with the correct therapy. Traditionally, identification of the spectrum of bacillary drug resistance takes several weeks to a few months, leading to under-treatment or incorrect treatment in many cases.

Read More →

RESIST-TB Clinical Trials Progress Report: clinical trials for drug-resistant TB

Visit the RESIST-TB Clinical Trials Progress Report to check out what trials are in development, enrolling and completed. The Clinical Trials Progress Report is available as a PDF here.

Read More →

RESIST-TB survey on your experience gaining or attempting to gain access to new TB drugs

The survey can be found here. It is prepared by RESIST-TB. RESIST-TB is a movement to promote and conduct research on the treatment and prevention of drug-resistant tuberculosis, with a commitment to address the substantial existing gaps in our knowledge and to help provide access to an effective cure and prophlyaxis of drug-resistant tuberculosis throughout the world.

Read More →

RESIST-TB: DR-TB Clinical Trial Progress Report

Curious what is going on in clinical trials for DR-TB? Visit RESIST-TB Progress Report: DR-TB Clinical Trials table to check out what trials are in development, enrolling and completed here.

Read More →

Page 5 of 5 · Total posts: 7

←First 4 5